47 results
PRE 14A
VRNA
Verona Pharma Plc
8 Mar 24
Preliminary proxy
4:18pm
or procedures, which, if not resolved to the satisfaction of
PwC, would have caused PwC to make reference to the matter in its report on the financial
8-K
EX-10.1
f5081zgk8q
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
nzeou7g408df81qq6
18 Dec 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K
EX-10.1
tb2h6dznya5qgrma0
1 May 23
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.1
vvda9aah2pv7l2m9rv
17 Oct 22
Entry into a Material Definitive Agreement
6:00am
8-K
46pnsnpseoiz
11 Aug 22
Other Events
5:46pm
8-K
EX-1.1
qbjsue
11 Aug 22
Other Events
5:46pm
424B5
ld1rg9
11 Aug 22
Prospectus supplement for primary offering
5:09pm
424B5
crtr9e
9 Aug 22
Prospectus supplement for primary offering
12:00am